$MRNA CEO, Stephen Bancel, recently deleted his Twitter account. Over the past 2 years he has sold over $400 million on stock. We will look at MRNAs price over the last 5 years, insider selling over this time period, and what a deleted Twitter account might indicate.MRNA Price Performance
Comparing the current price relative to MRNA’s 52 week high of $497.49, we see that MRNA is currently trading 67.6 % lower than the 52 week high price.
In mid 2019, MRNA was trading around $20 per share. In the middle of 2021 it reached an all time high of almost $500 per share. This is a 25x increase in share price, which is significant. This is important to note because until the pandemic hit, Stephen had not sold any of his shares.
Here is a quick snippet of Stephen’s corporate profile. He has been with Moderna for over 10 years.
Stéphane Bancel has served as Moderna’s Chief Executive Officer since October 2011 and as a member of Moderna’s board of directors since March 2011. Before joining the Company, Mr. Bancel served for five years as Chief Executive Officer of the French diagnostics company bioMérieux SA. From July 2000 to March 2006, he served in various roles at Eli Lilly and Company, including as Managing Director, Belgium and as Executive Director, Global Manufacturing Strategy and Supply Chain. Prior to Lilly, Mr. Bancel served as Asia-Pacific Sales and Marketing Director for bioMérieux.
Link to deleted account https://twitter.com/sbancel
